Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
about
A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.Role of tight junction proteins in gastroesophageal reflux diseaseWithdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial dataMechanism of acid hypersecretion post curative gastrinoma resectionEffect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls.Gastric acid hypersecretory states: recent insights and advances.Pharmaceutical principles of acid inhibitors: unmet needs.Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.Algorithm of medication review in frail older people: Focus on minimizing the use of high-risk medications.Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice.Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice.Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
P2860
Q30276528-FA1BDCAB-EF04-446B-8788-11CF3F2D5DFEQ31096619-E6BAC979-4C3D-42A7-857F-E23D39C82EA9Q33993694-4E03A96D-DC9A-4D36-85AE-635B2D2BA26DQ34345074-07347860-5801-412D-A905-3C7AA14E5C00Q35557414-B2D7F3E6-930E-40B1-A59B-BB4C8ABB6302Q37324412-C72E3157-5E8F-4931-AC38-EF76E31D1B63Q37474172-B3058545-A2B6-4295-9326-BEAC4816728EQ37957701-272F6FB2-4A44-42F2-858C-E359CA96E5A9Q38011261-55B8FF06-F56E-4881-A1D7-95A6FA0B1EEFQ38073333-CF563758-DABC-41B3-B399-E187601A2D14Q38109860-B46097A6-6464-457D-BE1F-ABBCE75C2AD3Q38266846-9C0DEB4F-676D-4B54-A8C1-C714E3D402CFQ38486082-7A0DEC2E-9E10-45B7-B1EC-CA0DE075EE51Q38580499-565F3EC4-2F62-42BE-9759-0B60007880F7Q39271435-F64512BC-26BF-4D7C-8F54-94578D3023F5Q40655375-EA719677-2081-46CD-A0C5-4A2CC0046C30Q43120420-547D1FE2-2E93-4D99-AD6F-B8BCCC50942EQ48124606-77499360-E2ED-478E-9892-A685854C4B41Q48263186-B1E55293-D463-4664-A2E0-C0546128240EQ55266404-FD8A4C25-814F-4E29-A81D-EE82DA4BFAED
P2860
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@ast
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@en
type
label
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@ast
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@en
prefLabel
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@ast
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@en
P2093
P1476
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
@en
P2093
P356
10.1111/J.1365-2036.2006.03171.X
P407
P577
2007-01-01T00:00:00Z